Trimethobenzamide mechanism of action?

How does trimethobenzamide work in the body?

Trimethobenzamide is an antiemetic (anti-nausea) drug. Its anti-nausea effect is mainly linked to blocking the brain pathways that trigger vomiting, especially signals related to the chemoreceptor trigger zone (CTZ). By interfering with those vomiting signals, it helps reduce nausea and vomiting [1].

What receptors or neurotransmitters does it affect?

Trimethobenzamide’s mechanism is described as an antagonism of dopamine-mediated emetic signaling in the central nervous system, which helps suppress the vomiting reflex [1].

Does it work the same way as other antiemetics?

Trimethobenzamide is often grouped with dopamine-antagonist antiemetics by virtue of its antiemetic mechanism via central dopamine effects [1]. Other common antiemetics may target different pathways (for example, serotonin 5-HT3 receptors or histamine receptors), but trimethobenzamide’s core effect is centered on blocking central emetic signaling.

What does this mean clinically (nausea vs. vomiting)?

Because its target is central control of the vomiting reflex, trimethobenzamide is used to prevent or treat nausea and vomiting rather than to treat the underlying cause (such as infection, migraine, or gastrointestinal irritation) [1].

Sources

1